Literature DB >> 20444651

Approaches to improve pain relief while minimizing opioid abuse liability.

Lynn R Webster1, Perry G Fine.   

Abstract

UNLABELLED: Two strategies should greatly improve pain management while minimizing opioid abuse. The first strategy involves the systematic implementation in every clinical practice of "universal precautions," a set of procedures that help physicians implement opioid therapy in a safe and controlled manner. These procedures include: 1) carefully assessing the patient's risk for opioid abuse; 2) selecting the most appropriate opioid therapy; 3) regularly monitoring the patient to evaluate the efficacy and tolerability of the treatment and to detect possible aberrant behaviors; and 4) mapping out solutions if abuse and/or addiction is detected, or in case of treatment failure. The second strategy involves the use of opioid formulations designed to deter or prevent product tampering and abuse. Results of clinical trials of new formulations of existing opioids (including oxycodone, morphine, and hydromorphone) suggest the potential for reduced abuse liability and, if approved, will be evaluated after launch for reduced real-world abuse. Integration of these formulations in clinical practices based on universal precautions should help further minimize the risk of opioid abuse while fostering appropriate prescribing to patients with indications for opioid therapy. PERSPECTIVE: Undertreated pain and prescription opioid abuse remain important public health problems. In the absence of strong empirical evidence, common sense dictates that a universal-precautions approach-a systematic and easily adopted process that clinicians can quickly put into practice-is advised to promote safe opioid prescribing. Abuse- and tamper-resistant opioid formulations are emerging tools that may enhance safe opioid prescribing; further research and postmarketing analysis will clarify their utility and role in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444651     DOI: 10.1016/j.jpain.2010.02.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  11 in total

1.  Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Irma H Benedek; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-06-20       Impact factor: 4.492

Review 2.  Roadmap to risk evaluation and mitigation strategies (REMS) success.

Authors:  John D Balian; Janice C Wherry; Rachpal Malhotra; Valerie Perentesis
Journal:  Ther Adv Drug Saf       Date:  2010-10

3.  Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.

Authors:  Jennifer Harman Ehrentraut; Kathleen Danielle Kern; Sarah A Long; Angel Qi An; Lane G Faughnan; Doralina L Anghelescu
Journal:  J Pediatr Psychol       Date:  2014-09-14

4.  American Society for Pain Management nursing position statement: pain management in patients with substance use disorders.

Authors:  June Oliver; Candace Coggins; Peggy Compton; Susan Hagan; Deborah Matteliano; Marsha Stanton; Barbara St Marie; Stephen Strobbe; Helen N Turner
Journal:  J Addict Nurs       Date:  2012-10       Impact factor: 1.476

Review 5.  The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.

Authors:  Barth Wilsey; J Hampton Atkinson; Thomas D Marcotte; Igor Grant
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

6.  A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Douglas Y Shapiro; Sandra D Comer
Journal:  Addiction       Date:  2013-03-13       Impact factor: 6.526

7.  American Society for Pain Management nursing position statement: pain management in patients with substance use disorders.

Authors:  June Oliver; Candace Coggins; Peggy Compton; Susan Hagan; Deborah Matteliano; Marsha Stanton; Barbara St Marie; Stephen Strobbe; Helen N Turner
Journal:  Pain Manag Nurs       Date:  2012-09       Impact factor: 1.929

Review 8.  Opioid therapy for chronic pain in the United States: promises and perils.

Authors:  Mark D Sullivan; Catherine Q Howe
Journal:  Pain       Date:  2013-09-11       Impact factor: 6.961

Review 9.  Perioperative Pain Control in Upper Extremity Surgery: Prescribing Patterns, Recent Developments, and Opioid-Sparing Treatment Strategies.

Authors:  Joseph T Labrum; Asif M Ilyas
Journal:  Hand (N Y)       Date:  2018-07-12

Review 10.  Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature.

Authors:  Marion S Greene; R Andrew Chambers
Journal:  Curr Addict Rep       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.